18F-FLUC PET/MR in Patients With Brain Mets

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT06159335
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Brain Metastasis
  • Immunotherapy, Active
  • Radiation Therapy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • F-Fluciclovine radiotracer — RADIATION
    Participants will receive PET radiotracer and MRI

Study Details

The goal of this clinical trial is to use new imaging methods to help in finding out whether the imaging shows that there is a tumor in people with a brain metastasis. The main question it aims to answer is whether positron emission tomography (PET) and magnetic resonance imaging (MRI) find cancerous tissue better than other types of imagining. Participants will undergo a single PET/MRI scan, followed by a separate MRI scan with a tracer. Study participation will last about 3 hours.

Key Dates

Start date
Jan 10, 2024
Status verified
Feb 2026
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: PET-MRI
    Participants will undergo F-Fluciclovine PET radiotracer and MRI

Primary Outcome Measure

Amino acid uptake into tumor tissue [ Time Frame: 3 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of WisconsinMadisonWisconsin53705-

Find similar trials in Madison, WI

By research site
University of Wisconsin· Madison, WI

Related Studies